First targeted therapy for rare mutation of gastrointestinal stromal tumors
The U.S. Food and Drug Administration (FDA) recently announced the approval of Blueprint Medicines Corporation’s avapritinib (Ayvakit) for the treatment…
Targeted Therapy
New findings from the American Cancer Society on reduced cancer mortality rates
Based on new findings from a 2020 American Cancer Society report, mortality rates from cancer have declined by 29% between…
Scientists can silence inflammatory gene responsible for a form of breast cancer
Scientists have found that they are able to “switch off,” or silence, a gene that is responsible for an aggressive…